Telemetrix sells business to focus on glucose project
This article was originally published in Clinica
Executive Summary
Canadian company CME Telemetrix, which is attempting to bring a non-invasive glucose monitoring device to market, is to sell its physiological monitoring business to concentrate on the glucose monitoring project.